Epigenetics Market Size, Share, Growth, Opportunities & Forecast 2031

The Epigenetics is the study of how behaviors and environment cause changes that affect the way genes work, without altering the underlying DNA sequence. These modifications act as switches, turning genes on or off, and can influence protein production. Unlike genetic changes, epigenetic marks are reversible, influenced by factors like diet, stress, and toxins, and can sometimes be inherited. The Epigenetics Market size is projected to reach USD 35.84 billion by 2031 from USD 11.12 billion in 2024. The market is expected to register a CAGR of 18.3% during 2025–2031.

Download PDF Copy@ https://www.theinsightpartners.com/sample/TIPHE100000971

𝐆𝐥𝐨𝐛𝐚𝐥 𝐓𝐨𝐩 𝐋𝐞𝐚𝐝𝐞𝐫𝐬 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

Promega Corp
Abcam Plc
Oxford Nanopore Technologies
QIAGEN NV
Thermo Fisher Scientific Inc.
Merck KGaA
Revvity Inc.
Active Motif
EpiGentek Group Inc
Agilent Technologies Inc.

By Application:

Oncology
Non-Oncology

By Technology:

DNA Methylation Analysis
Chromatin Immunoprecipitation Sequencing (ChIP-Seq)
Cleavage Under Targets and Tagmentation (CUT and Tag)
Assay for Transposase-Accessible Chromatin with Sequencing (ATAC-Seq)
Histone Modification Analysis
RNA Epigenetics
Single-cell Epigenomic Assays
Others

By End-User Industry:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
Others

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Ankit Mathur

Phone : +1-646-491-9876

E-mail : [email protected]